Permeability of endothelial monolayers to albumin is increased by bradykinin and inhibited by prostaglandins
Institut de Pharmacologie de Sherbrooke, Medical School, University of Sherbrooke, Sherbrooke, Quebec, Canada J1H 5N4 Using monolayers of bovine aortic endothelial cells (BAEC) in modified Boyden chambers, we examined the role of prostaglandins (PGs) in the bradykinin (BK)-induced increase of albumi...
Saved in:
Published in | American journal of physiology. Lung cellular and molecular physiology Vol. 280; no. 4; pp. 732 - L738 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.04.2001
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Institut de Pharmacologie de Sherbrooke, Medical School, University
of Sherbrooke, Sherbrooke, Quebec, Canada J1H 5N4
Using monolayers of
bovine aortic endothelial cells (BAEC) in modified Boyden chambers, we
examined the role of prostaglandins (PGs) in the bradykinin
(BK)-induced increase of albumin permeability. BK induced a
concentration-dependent increase of the permeability of BAEC, which
reached 49.9 ± 1% at the concentration of 10 8 M. Two inhibitors of the prostaglandin G/H synthase, indomethacin (2.88 µM) and ibuprofen (10 µM), potentiated BK-induced permeability 1.8- and 3.9-fold, respectively. Exogenously administered PGE 2 and iloprost, a stable analog of prostacyclin, attenuated the effect of
BK in a concentration-dependent manner. Butaprost equally reduced the
effect of BK, suggesting the participation of the EP 2
receptor in this phenomenon. However, the EP 4 -selective
antagonist AH-23848 did not significantly inhibit the protective effect
of PGE 2 . The inhibitory effect of PGE 2 was
reversed by the adenylate cyclase inhibitor MDL-12330A (10 µM). These
results suggest that BK-induced increase of permeability of BAEC
monolayer to 125 I-labeled albumin is negatively regulated
by PGs. This postulated autocrine activity of PGs may involve an
increase in the intracellular level of cAMP.
capillary permeability; iloprost; butaprost; prostaglandin
E 2 ; adenosine 3',5'-cyclic monophosphate; indomethacin; ibuprofen |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 1040-0605 1522-1504 |
DOI: | 10.1152/ajplung.2001.280.4.l732 |